The Effects of Aerobic Exercise in Patients With Primary Lower Extremity Lymphedema
Effects of Hospital-Based Aerobic Exercise Therapy on Exercise Capacity, Body Composition, Functional Level and Quality of Life in Patients With Primary Lower Extremity Lymphedema; Prospective Randomized Controlled Single Blind Trial
1 other identifier
interventional
35
1 country
1
Brief Summary
Our aim in this study is to evaluate the effects of lymphedema on exercise capacity, body composition, functional level and quality of life in lymphedema patients with primary lower extremity involvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2024
CompletedFirst Posted
Study publicly available on registry
March 25, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedMarch 27, 2024
March 1, 2024
6 months
March 17, 2024
March 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30-second sit-stand test (30-s chair-stand test, 30s-CST)
It is a test with proven validity and reliability that evaluates the patient's sit-to-stand activity, lower extremity strength and dynamic balance. The patient's sitting height is approximately 43 cm on a chair without arms; The patient is asked to sit with his back straight and straight, his arms crossed in front, his feet on the floor, and then he is asked to sit and stand within 30 seconds. The number of times he sits and stands gives the score of the test.
week 0, 4th week, 16th week
Secondary Outcomes (8)
Cardiopulmonary exercise test (CPET)
week 0, 4th week, 16th week
6-minute walk test (6MWT)
week 0, 4th week, 16th week
Circumference and volume measurement
week 0, 4th week, 16th week
Bioimpedance measurement
week 0, 4th week, 16th week
Lower Extremity Functional Scale (LEFS)
week 0, 4th week, 16th week
- +3 more secondary outcomes
Study Arms (2)
Hospital Exercise Group
ACTIVE COMPARATORAccording to the Cardiopulmonary Exercise test (CPET), the patients should exercise on the treadmill (5 minutes warm-up, 30 minutes exercise, 5 minutes cool-down) for 40 minutes (5 minutes warm-up, 30 minutes exercise, 5 minutes cool-down) at an exercise intensity of 50-60% of the individually recorded VO2 max (the maximum amount of oxygen that an individual can utilize during intense or maximal exercise) level in the patients. Aerobic exercise therapy will be organized to include treadmill.
Home Exercise Group
PLACEBO COMPARATORPatients will be asked to walk 40 minutes a day, 5 days a week, for 4 weeks. Training will be given for the first session in the hospital to ensure that the patient's walking pace is between 12-13 RPE (The Borg Rating of Perceived Exertion) according to the Modified Borg scale.
Interventions
According to the cardiopulmonary exercise (CPET) test, 40 minutes (5 minutes warm-up, 30 minutes exercise, 5 minutes cool-down) at an exercise intensity of 50-60% of the VO2 max (the maximum amount of oxygen that an individual can utilize during intense or maximal exercise) level recorded individually in patients, 5 days a week for 4 weeks.Both patient groups will be given lymphedema-specific remedial exercise program training. Anatolian Lymphedema Association lower extremity lymphedema exercise sheets will be delivered to the patients in writing, and training on exercise practices will be given face to face as a session by a physiotherapist at the physical therapy lymphedema outpatient clinic. Patients will be asked to perform these exercises daily as stated in the leaflet and in the number of repetitions. Patients will be given an exercise diary to ensure their compliance with exercise and will be asked to mark this form daily
He/she will be asked to walk 40 minutes a day, 5 days a week, for 4 weeks. Training will be given for the first session in the hospital to ensure that the patient's walking pace is between 12-13 RPE according to the Modified Borg scale.Both patient groups will be given lymphedema-specific remedial exercise program training. Anatolian Lymphedema Association lower extremity lymphedema exercise sheets will be delivered to the patients in writing, and training on exercise practices will be given face to face as a session by a physiotherapist at the physical therapy lymphedema outpatient clinic. Patients will be asked to perform these exercises daily as stated in the leaflet and in the number of repetitions. Patients will be given an exercise diary to ensure their compliance with exercise and will be asked to mark this form daily.Treatment compliance will be increased by making weekly phone calls to patients in order to increase treatment compliance and evaluate compliance.
Eligibility Criteria
You may qualify if:
- Patients who have completed complete decongestive therapy (CBT) Phase 1 treatment within the last 1 month, use Class 3 compression garments, and are scheduled for CBT Phase 2 treatment.
- Patients with stage 2-3 unilateral or bilateral primary lymphedema with lower extremity involvement
- Women and men aged 18-65
- Patients who agreed to participate in the study and received written voluntary consent form.
You may not qualify if:
- Patients who do not agree to participate in the study
- Patients without cooperation and compliance
- Presence of phlebo edema, lipedema, cellulitis, lymphocele
- History of lower extremity venous system disease
- Presence of acute infection
- History of malignancy
- Presence of acute/chronic lung disease (history of acute pulmonary embolism, acute bronchial asthma attack, chronic interstitial lung disease)
- Chronic liver failure
- Renal dysfunction
- Uncontrolled hypertension and diabetes mellitus
- Presence of orthopedic disease that may prevent walking (joint limitation, ankylosis, amputation)
- Use of medications known to affect physical performance, heart rate or metabolism (including Beta blockers)
- Patients who have been included in the CPR (Cardiopulmonary resuscitation) program in the last year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Sciences University, Kayseri Medicine Faculty, Kayseri City Hospital
Kayseri, 38080, Turkey (Türkiye)
Related Publications (4)
Adachi H. Cardiopulmonary Exercise Test. Int Heart J. 2017 Oct 21;58(5):654-665. doi: 10.1536/ihj.17-264. Epub 2017 Sep 30.
PMID: 28966333BACKGROUNDHamilton DM, Haennel RG. Validity and reliability of the 6-minute walk test in a cardiac rehabilitation population. J Cardiopulm Rehabil. 2000 May-Jun;20(3):156-64. doi: 10.1097/00008483-200005000-00003.
PMID: 10860197BACKGROUNDSakamoto M, Suematsu Y, Yano Y, Kaino K, Teshima R, Matsuda T, Fujita M, Tazawa R, Fujimi K, Miura SI. Depression and Anxiety Are Associated with Physical Performance in Patients Undergoing Cardiac Rehabilitation: A Retrospective Observational Study. J Cardiovasc Dev Dis. 2022 Jan 11;9(1):21. doi: 10.3390/jcdd9010021.
PMID: 35050231BACKGROUNDVerbrugghe J, Agten A, Stevens S, Hansen D, Demoulin C, O Eijnde B, Vandenabeele F, Timmermans A. Exercise Intensity Matters in Chronic Nonspecific Low Back Pain Rehabilitation. Med Sci Sports Exerc. 2019 Dec;51(12):2434-2442. doi: 10.1249/MSS.0000000000002078.
PMID: 31269004BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Fatma Gül Ülkü Demir, MD
Kayseri City Hospital
- PRINCIPAL INVESTIGATOR
Firdevs Akdeniz Çınar
Health Sciences University, Kayseri Medical Faculty
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor doctor
Study Record Dates
First Submitted
March 17, 2024
First Posted
March 25, 2024
Study Start
April 1, 2024
Primary Completion
October 1, 2024
Study Completion
October 1, 2024
Last Updated
March 27, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share